Oncos Therapeutics' Merger

Oncos Therapeutics raised a round of funding on June 12, 2015. Investors include Targovax.

Oncos is a privately funded clinical-stage biotechnology company focused on the development and commercialization of targeted cancer immunotherapy. Oncos' product candidates induce a tailored response…

Articles about Oncos Therapeutics' Merger: